|
1
|
Yarden Y and Pines G: The ERBB network: At
last, cancer therapy meets systems biology. Nat Rev Cancer.
12:553–563. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Casaletto JB and McClatchey AI: Spatial
regulation of receptor tyrosine kinases in development and cancer.
Nat Rev Cancer. 12:387–400. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paez JG, Jänne PA, Lee JC, Tracy S,
Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et
al: EGFR mutations in lung cancer: Correlation with clinical
response to gefitinib therapy. Science. 304:1497–1500. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Health Quality Ontario: Epidermal growth
factor receptor mutation (EGFR) testing for prediction of response
to EGFR-targeting tyrosine kinase inhibitor (TKI) drugs in patients
with advanced non-small-cell lung cancer: an evidence-based
analysis. Ont Health Technol Assess Ser. 10:1–48. 2010.
|
|
5
|
Chung C: Tyrosine kinase inhibitors for
epidermal growth factor receptor gene mutation-positive non-small
cell lung cancers: An update for recent advances in therapeutics. J
Oncol Pharm Pract. 22:461–476. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bennasroune A, Gardin A, Aunis D, Cremel G
and Hubert P: Tyrosine kinase receptors as attractive targets of
cancer therapy. Crit Rev Oncol Hematol. 50:23–38. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mendelsohn J and Baselga J: Epidermal
growth factor receptor targeting in cancer. Semin Oncol.
33:369–385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jura N, Endres NF, Engel K, Deindl S, Das
R, Lamers MH, Wemmer DE, Zhang X and Kuriyan J: Mechanism for
activation of the EGF receptor catalytic domain by the
juxtamembrane segment. Cell. 137:1293–1307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishimura M, Shin MS, Singhirunnusorn P,
Suzuki S, Kawanishi M, Koizumi K, Saiki I and Sakurai H:
TAK1-mediated serine/threonine phosphorylation of epidermal growth
factor receptor via p38/extracellular signal-regulated kinase:
NF-{kappa}B-independent survival pathways in tumor necrosis factor
alpha signaling. Mol Cell Biol. 29:5529–5539. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Refaat A, Aminullah, Zhou Y, Kawanishi M,
Tomaru R, Abdelhamed S, Shin MS, Koizumi K, Yokoyama S, Saiki I and
Sakurai H: Role of tyrosine kinase-independent phosphorylation of
EGFR with activating mutation in cisplatin-treated lung cancer
cells. Biochem Biophys Res Commun. 458:856–861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zwang Y and Yarden Y: p38 MAP kinase
mediates stress-induced internalization of EGFR: Implications for
cancer chemotherapy. EMBO J. 25:4195–4206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong J, Taylor P and Moran MF: Proteomic
analysis of the EGFR interactome and post-translational
modifications associated with receptor endocytosis in response to
EGF and stress. Mol Cell Proteomics. 13:1644–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adachi S, Natsume H, Yamauchi J,
Matsushima-Nishiwaki R, Joe AK, Moriwaki H and Kozawa O: p38 MAP
kinase controls EGF receptor downregulation via phosphorylation at
Ser1046/1047. Cancer Lett. 277:108–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tan X, Lambert PF, Rapraeger AC and
Anderson RA: Stress-induced EGFR trafficking: Mechanisms, functions
and therapeutic implications. Trends Cell Biol. 26:352–366. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan X, Thapa N, Sun Y and Anderson RA: A
kinase-independent role for EGF receptor in autophagy initiation.
Cell. 160:145–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:573–584.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka T, Zhou Y, Ozawa T, Okizono R,
Banba A, Yamamura T, Oga E, Muraguchi A and Sakurai H:
Ligand-activated epidermal growth factor receptor (EGFR) signaling
governs endocytic trafficking of unliganded receptor monomers by
non-canonical phosphorylation. J Biol Chem. 293:2288–2301. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Refaat A, Zhou Y, Suzuki S, Takasaki I,
Koizumi K, Yamaoka S, Tabuchi Y, Saiki I and Sakurai H: Distinct
roles of transforming growth factor-beta-activated kinase 1
(TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in
human T cell lymphotropic virus 1-transformed T helper 17 cells
producing interleukin-9. J Biol Chem. 286:21092–21099. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou Y, Yamada N, Tanaka T, Hori T,
Yokoyama S, Hayakawa Y, Yano S, Fukuoka J, Koizumi K, Saiki I and
Sakurai H: Crucial roles of RSK in cell motility by catalysing
serine phosphorylation of EphA2. Nat Commun. 6:76792015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou Y, Tanaka T, Sugiyama N, Yokoyama S,
Kawasaki Y, Sakuma T, Ishihama Y, Saiki I and Sakurai H:
p38-Mediated phosphorylation of Eps15 endocytic adaptor protein.
FEBS Lett. 588:131–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kinoshita E and Kinoshita-Kikuta E:
Improved Phos-tag SDS-PAGE under neutral pH conditions for advanced
protein phosphorylation profiling. Proteomics. 11:319–323. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Q, Villeneuve G and Wang Z: Control
of epidermal growth factor receptor endocytosis by receptor
dimerization, rather than receptor kinase activation. EMBO Rep.
6:942–948. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garrett TP, McKern NM, Lou M, Elleman TC,
Adams TE, Lovrecz GO, Zhu HJ, Walker F, Frenkel MJ, Hoyne PA, et
al: Crystal structure of a truncated epidermal growth factor
receptor extracellular domain bound to transforming growth factor
alpha. Cell. 110:763–773. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hornbeck PV, Kornhauser JM, Tkachev S,
Zhang B, Skrzypek E, Murray B, Latham V and Sullivan M:
PhosphoSitePlus: A comprehensive resource for investigating the
structure and function of experimentally determined
post-translational modifications in man and mouse. Nucleic Acids
Res. 40:D261–D270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato K, Shin MS, Sakimura A, Zhou Y,
Tanaka T, Kawanishi M, Kawasaki Y, Yokoyama S, Koizumi K, Saiki I
and Sakurai H: Inverse correlation between Thr-669 and constitutive
tyrosine phosphorylation in the asymmetric epidermal growth factor
receptor dimer conformation. Cancer Sci. 104:1315–1322. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Countaway JL, Nairn AC and Davis RJ:
Mechanism of desensitization of the epidermal growth factor
receptor protein-tyrosine kinase. J Biol Chem. 267:1129–1140.
1992.PubMed/NCBI
|
|
28
|
Tan X, Sun Y, Thapa N, Liao Y, Hedman AC
and Anderson RA: LAPTM4B is a PtdIns(4,5)P2 effector that regulates
EGFR signaling, lysosomal sorting and degradation. EMBO J.
34:475–490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tomas A, Vaughan SO, Burgoyne T, Sorkin A,
Hartley JA, Hochhauser D and Futter CE: WASH and
Tsg101/ALIX-dependent diversion of stress-internalized EGFR from
the canonical endocytic pathway. Nat Commun. 6:73242015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tomas A, Futter CE and Eden ER: EGF
receptor trafficking: Consequences for signaling and cancer. Trends
Cell Biol. 24:26–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen PH, Bendris N, Hsiao YJ, Reis CR,
Mettlen M, Chen HY, Yu SL and Schmid SL: Crosstalk between
CLCb/Dyn1-mediated adaptive clathrin-mediated endocytosis and
epidermal growth factor receptor signaling increases metastasis.
Dev Cell. 40:278–288.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmid SL: Reciprocal regulation of
signaling and endocytosis: Implications for the evolving cancer
cell. J Cell Biol. 216:2623–2632. 2017.PubMed/NCBI
|
